Studies Introducing Costimulation Blockade for Vascularized Composite Allografts in Nonhuman Primates
暂无分享,去创建一个
A. Kirk | M. Song | K. Samy | A. Farris | F. Leopardi | E. Strobert | L. Stempora | L. Cendales | A. Freitas | Jamar Jenkins
[1] A. Mehta,et al. Inhibition of αvβ6 Promotes Acute Renal Allograft Rejection in Nonhuman Primates , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] Geoffroy C. Sisk,et al. Vascularized composite tissue allotransplantation – state of the art , 2013, Clinical transplantation.
[3] Vikesh K. Singh,et al. Sirolimus based immunosuppression is associated with need for early repeat therapeutic ERCP in liver transplant patients with anastomotic biliary stricture. , 2013, Annals of hepatology.
[4] A. Mehta,et al. Belatacept and Sirolimus Prolong Nonhuman Primate Renal Allograft Survival Without a Requirement for Memory T Cell Depletion , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] C. Larsen,et al. Belatacept and Sirolimus Prolong Nonhuman Primate Islet Allograft Survival: Adverse Consequences of Concomitant Alefacept Therapy , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[6] B. Nashan,et al. Wound Healing Complications and the Use of Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation: A Critical Review of the Literature , 2012, Transplantation.
[7] L. Rostaing,et al. Three‐Year Outcomes from BENEFIT, a Randomized, Active‐Controlled, Parallel‐Group Study in Adult Kidney Transplant Recipients , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] S. Schneeberger,et al. Achievements and challenges in composite tissue allotransplantation , 2011, Transplant International.
[9] P. Grimbert,et al. Feasibility, Reproducibility, Risks and Benefits of Face Transplantation: A Prospective Study of Outcomes , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] A. Mehta,et al. Selective Targeting of Human Alloresponsive CD8+ Effector Memory T Cells Based on CD2 Expression , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[11] F. Schuind,et al. The International Registry on Hand and Composite Tissue Transplantation , 2010, Transplantation.
[12] P. Cavadas,et al. Improvement in renal function after late conversion to sirolimus-based immunosuppression in composite tissue allotransplantation. , 2010, Transplantation.
[13] E. Rodriguez,et al. Clinical Facial Composite Tissue Allotransplantation: A Review of the First Four Global Experiences and Future Implications , 2010, Plastic and reconstructive surgery.
[14] J. Niezgoda,et al. Impaired lower extremity wound healing secondary to sirolimus after kidney transplantation. , 2009, The journal of the American College of Certified Wound Specialists.
[15] T. McCormick,et al. Alefacept in the treatment of psoriasis. , 2008, Clinics in dermatology.
[16] A. Kirk,et al. The Banff 2007 Working Classification of Skin‐Containing Composite Tissue Allograft Pathology , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] M. Zembala,et al. Surgical wound‐healing complications in heart transplant recipients treated with rapamycin , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[18] A. Kirk,et al. Composite Tissue Allotransplantation: Development of a Preclinical Model in Nonhuman Primates , 2005, Transplantation.
[19] F. Schuind,et al. The International Registry on Hand and Composite Tissue Transplantation , 2005, Transplantation.
[20] P. Linsley,et al. Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[21] D. Kahn,et al. Effect of rapamycin on the healing of the bile duct. , 2005, Transplantation proceedings.
[22] N. Kenyon,et al. Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates. , 2002, Diabetes.
[23] Position paper on the initiation of clinical trials of xenotransplantation The American Society of Transplantation and The American Society of Transplant Surgeons , 2000, Xenotransplantation.
[24] T. Strom,et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance , 1999, Nature Medicine.
[25] W. Buurman,et al. Transplant International Official Journal of the European Society for Organ Transplantation , 1992, Springer Berlin Heidelberg.